TuHURA Biosciences, Inc. (HURA)
2.05
-0.08
(-3.76%)
USD |
NASDAQ |
Sep 23, 16:00
2.05
0.00 (0.00%)
Pre-Market: 09:08
TuHURA Biosciences Total Liabilities (Quarterly) : 13.25M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.25M |
| March 31, 2026 | 6.515M |
| December 31, 2025 | 6.421M |
| September 30, 2025 | 8.919M |
| June 30, 2025 | 15.17M |
| March 31, 2025 | 4.782M |
| December 31, 2024 | 5.373M |
| September 30, 2024 | 29.88M |
| June 30, 2024 | |
| March 31, 2024 | 1.524M |
| December 31, 2023 | 2.049M |
| September 30, 2023 | 3.503M |
| June 30, 2023 | 3.248M |
| March 31, 2023 | 2.954M |
| December 31, 2022 | 3.319M |
| September 30, 2022 | 3.592M |
| June 30, 2022 | 4.153M |
| March 31, 2022 | 3.412M |
| December 31, 2021 | 3.616M |
| September 30, 2021 | 3.18M |
| June 30, 2021 | 2.962M |
| March 31, 2021 | 2.735M |
| December 31, 2020 | 2.904M |
| September 30, 2020 | 2.577M |
| June 30, 2020 | 2.675M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.382M |
| December 31, 2019 | 1.027M |
| September 30, 2019 | 1.339M |
| June 30, 2019 | 2.070M |
| March 31, 2019 | 1.198M |
| December 31, 2018 | 1.268M |
| September 30, 2018 | 1.079M |
| June 30, 2018 | 1.640M |
| March 31, 2018 | 2.017M |
| December 31, 2017 | 2.232M |
| September 30, 2017 | 1.529M |
| June 30, 2017 | 1.332M |
| March 31, 2017 | 1.111M |
| December 31, 2016 | 0.8922M |
| September 30, 2016 | 1.073M |
| June 30, 2016 | 1.497M |
| March 31, 2016 | 1.843M |
| December 31, 2015 | 2.068M |
| September 30, 2015 | 3.546M |
| June 30, 2015 | 3.397M |
| March 31, 2015 | 2.196M |
| December 31, 2014 | 2.042M |
| September 30, 2014 | 3.976M |
| June 30, 2014 | 5.905M |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.75M |
| Shareholders Equity (Quarterly) | 18.50M |
| Debt to Equity Ratio | 0.2166 |
| Current Ratio | 0.1789 |
| Net Debt Paydown Yield | -0.52% |